Cancer-Associated Thrombosis: Beyond Clinical Practice Guidelines-A Multidisciplinary (SEMI-SEOM-SETH) Expert Consensus
- PMID: 31249964
- PMCID: PMC6524906
- DOI: 10.1055/s-0038-1675577
Cancer-Associated Thrombosis: Beyond Clinical Practice Guidelines-A Multidisciplinary (SEMI-SEOM-SETH) Expert Consensus
Abstract
Despite the growing interest and improved knowledge about venous thromboembolism in cancer patients in the last years, there are still many unsolved issues. Due to the limitations of the available literature, evidence-based clinical practice guidelines are not able to give solid recommendations for challenging scenarios often present in the setting of cancer-associated thrombosis (CAT). A multidisciplinary expert panel from three scientific societies-Spanish Society of Internal Medicine (SEMI), Spanish Society of Medical Oncology (SEOM), and Spanish Society Thrombosis and Haemostasis (SETH)-agreed on 12 controversial questions regarding prevention and management of CAT, which were thoroughly reviewed to provide further guidance. The suggestions presented herein may facilitate clinical decisions in specific complex circumstances, until these can be made leaning on reliable scientific evidence.
Keywords: cancer; prophylaxis; pulmonary embolism; treatment; venous thrombosis.
Conflict of interest statement
E.G. Speaker honoraria: Rovi and Leo Pharma; advisory board: Sanofi, Leo Pharma, and Daiichi-Sankyo.
A.M. Speaker honoraria: Rovi; advisory board: Sanofi, Leo Pharma, and Daiichi-Sankyo.
R.L. Speaker honoraria: Rovi and Boehringer-Ingelheim; advisory board: Sanofi, Leo Pharma, and BMS. Research grant: Rovi.
All other authors declare no relevant conflict of interest associated with this work.
Similar articles
-
[Polish guidelines for the prevention and treatment of venous thromboembolism. 2012 update].Pol Arch Med Wewn. 2012;122 Suppl 2:3-74. Pol Arch Med Wewn. 2012. PMID: 23385605 Polish.
-
Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETH.Med Clin (Barc). 2021 May 7;156(9):463.e1-463.e30. doi: 10.1016/j.medcli.2020.09.022. Epub 2021 Jan 16. Med Clin (Barc). 2021. PMID: 33461840 English, Spanish.
-
FOTROCAN Delphi consensus statement regarding the prevention and treatment of cancer-associated thrombosis in areas of uncertainty and low quality of evidence.Clin Transl Oncol. 2017 Aug;19(8):997-1009. doi: 10.1007/s12094-017-1632-3. Epub 2017 Feb 27. Clin Transl Oncol. 2017. PMID: 28243988
-
National Consensus on the Diagnosis, Risk Stratification and Treatment of Patients with Pulmonary Embolism. Spanish Society of Pneumology and Thoracic Surgery (SEPAR). Society Española Internal Medicine (SEMI). Spanish Society of Thrombosis and Haemostasis (SETH). Spanish Society of Cardiology (ESC). Spanish Society of Medicine Accident and Emergency (SEMES). Spanish Society of Angiology and Surgery Vascular (SEACV).Arch Bronconeumol. 2013 Dec;49(12):534-47. doi: 10.1016/j.arbres.2013.07.008. Epub 2013 Sep 14. Arch Bronconeumol. 2013. PMID: 24041726 No abstract available.
-
[Polish guidelines for the prevention and treatment of venous thromboembolism: 2009 update].Pol Arch Med Wewn. 2009;119 Suppl 1:1-69. Pol Arch Med Wewn. 2009. PMID: 19841614 Review. Polish.
Cited by
-
Outcome of antithrombotic therapy in cancer patients with catheter-related thrombosis: a systematic review.Front Cardiovasc Med. 2023 Dec 12;10:1290822. doi: 10.3389/fcvm.2023.1290822. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 38162134 Free PMC article. Review.
-
ONKOTEV Score as a Predictive Tool for Thromboembolic Events in Pancreatic Cancer-A Retrospective Analysis.Oncologist. 2020 Feb;25(2):e284-e290. doi: 10.1634/theoncologist.2019-0510. Epub 2019 Oct 22. Oncologist. 2020. PMID: 32043787 Free PMC article.
-
Is There a Role for Growth and Differentiation Factor-15 in B-Cell Lymphoproliferative Neoplasms?Indian J Hematol Blood Transfus. 2024 Apr;40(2):213-219. doi: 10.1007/s12288-023-01695-6. Epub 2023 Sep 17. Indian J Hematol Blood Transfus. 2024. PMID: 38708149 Free PMC article.
-
Differences in Venous Thromboembolism Prevention and Outcome between Hospitalized Patients with Solid and Hematologic Malignancies.TH Open. 2019 May 30;3(2):e153-e156. doi: 10.1055/s-0039-1692203. eCollection 2019 Apr. TH Open. 2019. PMID: 31259297 Free PMC article. No abstract available.
-
Cost of Venous Thromboembolic Disease in Patients with Lung Cancer: Costecat Study.Int J Environ Res Public Health. 2021 Jan 6;18(2):394. doi: 10.3390/ijerph18020394. Int J Environ Res Public Health. 2021. PMID: 33419138 Free PMC article.
References
-
- Lyman G H, Khorana A A, Kuderer N M et al.Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(17):2189–2204. - PubMed
-
- Guyatt G H, Akl E A, Crowther M, Gutterman D D, Schuünemann H J; American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel.Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 2012141(2, Suppl):7S–47S. - PMC - PubMed
-
- Mandalà M, Falanga A, Roila F; ESMO Guidelines Working Group.Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines Ann Oncol 20112206vi85–vi92. - PubMed
-
- Farge D, Debourdeau P, Beckers M et al.International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost. 2013;11(01):56–70. - PubMed
-
- Muñoz A J, Viñolas N, Cubedo R, Isla D. SEOM guidelines on thrombosis in cancer patients. Clin Transl Oncol. 2011;13(08):592–596. - PubMed
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous